Tumor progression to the metastatic state involves structural modifications in DNA markedly different from those associated with primary tumor formation
breast cancer;
tumor metastasis;
DNA damage;
free radicals;
Fourier transform-infrared spectroscopy;
D O I:
10.1073/pnas.93.24.14047
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Wavenumber-absorbance relationships of infrared spectra of DNA analyzed by principal components analysis may be expressed as points in space. Each point represents a highly discriminating measure of DNA structure. Structural modifications of DNA, such as those induced by free radicals, alter vibrational and rotational motion and consequently change the spatial location of the points, Using this technology to analyze breast tumor DNA, we revealed a 94 degrees difference in direction between the progression of normal DNA --> primary tumor DNA and the progression of primary tumor DNA --> metastatic tumor DNA (P < 0.001), This sharp directional change was accompanied by a substantial increase in the structural diversity of the metastatic tumor DNA (P = 0.003), which, on the basis of the volume of the core cluster of points, could comprise as many as 11 x 10(9) different phenotypes, This suggests that the heterogeneity and varied physiological properties known to characterize malignant tumor cell populations may at least partially arise from these diverse phenotypes. The evidence suggests that the progression to the metastatic state involves structural modifications in DNA that are markedly different from the modifications associated with the formation of the primary tumor. Overall, the findings of this and earlier studies imply that the observed DNA alterations are a pivotal factor in the etiology of breast cancer and a formidable barrier to overcome in intervention to control the disease, In terms of cancer etiology and prediction, the technology described has potentially wide application to studies in which the structural status of DNA is an important consideration.
机构:
Natl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
Natl Canc Ctr Hosp E, Div Thorac Surg, Kashiwa, Chiba 2778577, JapanNatl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
Aokage, Keiju
Ishii, Genichiro
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, JapanNatl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
Ishii, Genichiro
Yoshida, Junji
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp E, Div Thorac Surg, Kashiwa, Chiba 2778577, JapanNatl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
Yoshida, Junji
Hishida, Tomoyuki
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp E, Div Thorac Surg, Kashiwa, Chiba 2778577, JapanNatl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
Hishida, Tomoyuki
Nishimura, Mitsuyo
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp E, Div Thorac Surg, Kashiwa, Chiba 2778577, JapanNatl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
Nishimura, Mitsuyo
Nagai, Kanji
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp E, Div Thorac Surg, Kashiwa, Chiba 2778577, JapanNatl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
Nagai, Kanji
Ochiai, Atsushi
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, JapanNatl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan